StonvexLoading…
StonvexStonvexStonvexCore line items from MDXH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $107.88M | $90.05M | $70.19M | $37.05M |
Operating Income | $-14.41M | $-24.72M | $-27.33M | $-37.90M |
Net Income | $-33.52M | $-38.07M | $-43.10M | $-44.04M |
EPS (Diluted) | $-0.67 | $-1.16 | $-1.66 | $-2.78 |
Total Assets | $147.95M | $157.33M | $129.13M | $119.14M |
Total Liabilities | $160.05M | $142.49M | $121.92M | $109.82M |
Cash & Equivalents | $29.03M | $46.80M | $22.38M | $15.50M |
Free Cash Flow OCF − CapEx | $-3.35M | $-19.72M | $-24.24M | $-36.91M |
Shares Outstanding | 1.87M | 22.21M | 10.75M | Not available |